SlideShare a Scribd company logo
Val in Crs
MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% COMPANY MAT MTH
77529 100 6.7 6636 100 10.4 IPM
1 1 4218 5.44 15.8 349 5.26 16.1 Sun Pharma 1 1
2 2 3838 4.95 6.2 315 4.74 11.7 Cipla 2 2
3 3 3082 3.97 5.7 258 3.89 7.2 Zydus Cadila 4 3
4 5 3060 3.95 2.1 242 3.65 4.1 Ranbaxy 3 4
5 4 2759 3.56 5.7 246 3.71 14.8 Mankind 8 8
6 8 2697 3.48 -1.1 220 3.31 -1.1 Abbott HC 6 7
7 7 2694 3.47 -15.5 226 3.41 -7.0 Glaxo 5 6
8 6 2621 3.38 12.7 231 3.49 20.6 Lupin 7 5
9 9 2403 3.10 9.1 207 3.13 8.0 Alkem 9 9
10 11 2244 2.89 3.2 185 2.79 4.8 Pfizer 10 12
11 10 2102 2.71 13.3 200 3.01 29.5 Macleods 11 10
12 12 1975 2.55 14.1 185 2.79 26.6 Intas 12 11
13 13 1942 2.51 0.6 172 2.59 7.7 Sanofi-India 13 13
14 14 1902 2.45 14.7 170 2.56 17.1 Aristo 15 15
15 15 1724 2.22 2.7 156 2.34 12.0 Torrent 14 14
16 18 1688 2.18 16.7 136 2.05 16.9 Glenmark 16 17
17 16 1658 2.14 7.2 147 2.22 17.4 Dr. Reddys 17 16
18 17 1560 2.01 10.6 137 2.07 15.6 Micro Lab 19 19
19 19 1528 1.97 8.4 132 1.99 13.5 Abbott 18 18
20 22 1410 1.82 8.5 115 1.74 3.6 USV 20 22
21 20 1400 1.81 21.5 123 1.86 28.6 Ipca 21 20
22 21 1345 1.73 22.0 118 1.78 23.8 Emcure 22 21
23 23 1230 1.59 4.7 98 1.48 8.7 Wockhardt 23 23
24 24 1131 1.46 -1.5 93 1.40 -2.6 Novartis 24 24
25 25 1064 1.37 10.2 85 1.28 9.1 Alembic 25 25
26 27 831 1.07 3.9 66 0.99 -9.8 Zuventus 27 28
27 26 821 1.06 3.6 71 1.07 15.1 FDC 26 26
28 28 799 1.03 8.9 64 0.97 9.4 Unichem 28 27
29 29 686 0.89 14.7 61 0.93 7.3 Novo Nordisk 29 29
30 30 613 0.79 10.0 54 0.81 3.5 Cadila 30 30
31 32 599 0.77 7.1 51 0.76 12.8 Indoco Remedies 32 33
32 31 575 0.74 12.3 52 0.78 17.4 Franco 33 31
33 33 570 0.74 22.5 50 0.75 8.9 Eris 31 32
34 36 500 0.64 15.8 41 0.61 8.6 MSD 34 35
35 34 477 0.62 5.4 43 0.64 19.4 Himalaya 35 34
36 35 470 0.61 10.4 41 0.62 12.2 Merck 36 36
37 39 428 0.55 2.5 35 0.53 14.9 Blue Cross 38 41
38 37 412 0.53 11.4 39 0.58 19.5 JB Chemicals 37 37
39 45 392 0.51 13.6 29 0.43 -7.6 Astrazeneca 39 46
40 38 378 0.49 -0.2 37 0.55 7.9 Raptakos, Brett 40 38
41 41 378 0.49 -12.7 34 0.51 -13.2 Bharat Serums 41 40
42 40 378 0.49 23.7 34 0.52 21.5 Meyer Organics 42 39
43 51 349 0.45 11.6 27 0.40 10.3 Hetero 47 55
44 43 342 0.44 14.4 33 0.49 16.9 Medley 45 43
45 47 332 0.43 9.4 29 0.43 12.3 Janssen 43 45
46 44 331 0.43 9.8 31 0.47 14.7 Wallace 49 44
With Bonus Units at Full Value Witho
Rank MAT June-14 Jun-14 Rank
47 49 331 0.43 1.1 28 0.42 5.2 Win-Medicare 44 49
48 42 330 0.43 36.8 33 0.49 52.6 Akumentis 46 42
49 58 321 0.41 8.9 23 0.34 8.9 Fourrts 50 58
50 46 311 0.40 2.6 29 0.43 0.1 Albert David 48 48
Val (Cr) MS% GR% Val (Cr) MS% GR%
74585 100 6.8 6395 100 10.9
4123 5.53 14.9 343 5.36 16.4
3605 4.83 9.1 296 4.63 13.9
2893 3.88 5.6 242 3.79 6.5
2960 3.97 2.1 234 3.67 4.2
2339 3.14 7.4 212 3.31 18.5
2612 3.50 -1.5 213 3.34 -0.5
2663 3.57 -14.7 224 3.51 -5.6
2564 3.44 12.6 227 3.55 21.2
2237 3.00 9.3 194 3.04 9.8
2193 2.94 3.5 182 2.84 5.3
1970 2.64 13.0 187 2.93 29.5
1951 2.62 13.6 183 2.86 26.8
1907 2.56 0.4 168 2.63 8.1
1674 2.24 12.0 148 2.32 15.3
1689 2.26 3.0 152 2.38 12.1
1639 2.20 16.3 132 2.06 16.3
1624 2.18 6.3 144 2.26 17.1
1490 2.00 11.2 131 2.05 15.8
1517 2.03 8.0 131 2.05 13.6
1404 1.88 8.4 115 1.80 3.7
1332 1.79 21.4 118 1.85 30.2
1318 1.77 22.2 116 1.81 23.9
1206 1.62 4.5 97 1.51 9.3
1092 1.46 -0.8 90 1.41 -1.3
1032 1.38 10.8 83 1.30 10.3
793 1.06 4.2 63 0.98 -9.7
798 1.07 3.4 69 1.08 14.2
782 1.05 8.2 63 0.99 9.3
685 0.92 14.6 61 0.96 7.1
591 0.79 9.9 52 0.81 3.5
561 0.75 7.3 47 0.74 12.7
554 0.74 11.7 50 0.78 17.2
567 0.76 22.3 49 0.77 8.9
498 0.67 15.4 40 0.63 7.7
475 0.64 5.0 43 0.67 19.8
458 0.61 9.0 40 0.63 11.1
393 0.53 4.2 33 0.51 14.7
396 0.53 11.3 37 0.58 19.7
387 0.52 12.8 28 0.44 -7.5
373 0.50 -0.4 36 0.57 8.0
371 0.50 -13.1 33 0.52 -12.8
366 0.49 23.6 33 0.52 21.9
318 0.43 12.0 24 0.38 10.7
325 0.44 15.1 31 0.49 16.9
332 0.44 9.4 28 0.45 12.3
305 0.41 15.5 30 0.48 27.6
Without Bonus Units
MAT June-14 Jun-14
326 0.44 -0.3 27 0.43 3.4
324 0.43 38.6 32 0.50 53.0
304 0.41 7.9 22 0.34 8.4
305 0.41 2.6 28 0.44 -0.1

More Related Content

What's hot

regulatory requirements for drug approval ( IP-2 / UNIT -3 )
regulatory requirements for drug approval ( IP-2  / UNIT -3 )regulatory requirements for drug approval ( IP-2  / UNIT -3 )
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
JAYACHANDRA AKUTHOTA
 
thin layer chromatography
thin layer chromatographythin layer chromatography
thin layer chromatography
katta amulya
 
PHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENTPHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENT
DeepthiKolluru1
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
Sagar Savale
 
Tablet granulation tech
Tablet granulation techTablet granulation tech
Tablet granulation tech
GEORGESAHA
 
Herb drugs standardization
Herb drugs standardizationHerb drugs standardization
Herb drugs standardization
Hyderabad, Andhra Pradesh
 
Gas Chromatography
Gas ChromatographyGas Chromatography
Gas Chromatography
Rahul Krishnan
 
Powders fineness determination
Powders fineness determinationPowders fineness determination
Powders fineness determination
irtizaashaq
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
JAYACHANDRA AKUTHOTA
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
Shaik Sana
 
Thin layer chromatography- instrumental analysis.
Thin layer chromatography- instrumental analysis. Thin layer chromatography- instrumental analysis.
Thin layer chromatography- instrumental analysis.
SIVASWAROOP YARASI
 
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdfDetails-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
SameepShukla
 
Instrumentation IR Spectroscopy: Detectors
Instrumentation IR Spectroscopy: DetectorsInstrumentation IR Spectroscopy: Detectors
Instrumentation IR Spectroscopy: Detectors
Vrushali Tambe
 
Comparison of herbal pharmacopoeias
Comparison of herbal pharmacopoeiasComparison of herbal pharmacopoeias
Comparison of herbal pharmacopoeias
Dr-Jitendra Patel
 
Technology transfer.pptx
Technology transfer.pptxTechnology transfer.pptx
Technology transfer.pptx
AshwiniBhoir2
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
Sagar Savale
 
Preformulation Studies
Preformulation  StudiesPreformulation  Studies
Preformulation Studies
Naimat afridi
 
Overview of otc market
Overview of otc marketOverview of otc market
Overview of otc market
sanjuji
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
Raj Tiwari
 
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
Naman Ruhela
 

What's hot (20)

regulatory requirements for drug approval ( IP-2 / UNIT -3 )
regulatory requirements for drug approval ( IP-2  / UNIT -3 )regulatory requirements for drug approval ( IP-2  / UNIT -3 )
regulatory requirements for drug approval ( IP-2 / UNIT -3 )
 
thin layer chromatography
thin layer chromatographythin layer chromatography
thin layer chromatography
 
PHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENTPHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENT
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
Tablet granulation tech
Tablet granulation techTablet granulation tech
Tablet granulation tech
 
Herb drugs standardization
Herb drugs standardizationHerb drugs standardization
Herb drugs standardization
 
Gas Chromatography
Gas ChromatographyGas Chromatography
Gas Chromatography
 
Powders fineness determination
Powders fineness determinationPowders fineness determination
Powders fineness determination
 
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
REGULATORY AFFAIRS ( IP-2 / UNIT 3 )
 
Regulatory agencies
Regulatory agenciesRegulatory agencies
Regulatory agencies
 
Thin layer chromatography- instrumental analysis.
Thin layer chromatography- instrumental analysis. Thin layer chromatography- instrumental analysis.
Thin layer chromatography- instrumental analysis.
 
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdfDetails-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
Details-of-Projects-B-Pharm-and-M-Pharm-Final-Year.pdf
 
Instrumentation IR Spectroscopy: Detectors
Instrumentation IR Spectroscopy: DetectorsInstrumentation IR Spectroscopy: Detectors
Instrumentation IR Spectroscopy: Detectors
 
Comparison of herbal pharmacopoeias
Comparison of herbal pharmacopoeiasComparison of herbal pharmacopoeias
Comparison of herbal pharmacopoeias
 
Technology transfer.pptx
Technology transfer.pptxTechnology transfer.pptx
Technology transfer.pptx
 
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...UV Spectrophotometric Method Development and Validation for Quantitative Esti...
UV Spectrophotometric Method Development and Validation for Quantitative Esti...
 
Preformulation Studies
Preformulation  StudiesPreformulation  Studies
Preformulation Studies
 
Overview of otc market
Overview of otc marketOverview of otc market
Overview of otc market
 
USFDA GUIDLINES
USFDA GUIDLINESUSFDA GUIDLINES
USFDA GUIDLINES
 
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
DRA (Drug Regulatory Affairs) , RA (Regulatory Affairs)
 

Viewers also liked

India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015
QuintilesIMS Asia Pacific
 
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACSIndian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Anup Soans
 
Indian Pharma Market 2015
Indian Pharma Market 2015 Indian Pharma Market 2015
Indian Pharma Market 2015
Nitesh Bhele
 
Indian Pharma Market - IPM Overview June 2015
Indian Pharma Market - IPM Overview June 2015Indian Pharma Market - IPM Overview June 2015
Indian Pharma Market - IPM Overview June 2015
Anup Soans
 
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewindian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
bipindapin
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Irish Pereira
 
Indian Pharma Top 50 Companies - May 2014
Indian Pharma Top 50 Companies - May 2014Indian Pharma Top 50 Companies - May 2014
Indian Pharma Top 50 Companies - May 2014
Anup Soans
 
Indian Pharma Industry
Indian Pharma IndustryIndian Pharma Industry
Indian Pharma Industry
rvmfinishingschool
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
Sushant Mishra
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
Chandni Sahgal
 
India Market Reflection Report Feb 2015
India Market Reflection Report Feb 2015India Market Reflection Report Feb 2015
India Market Reflection Report Feb 2015
QuintilesIMS Asia Pacific
 
Indian Pharma Market Top 50 Highlights
Indian Pharma Market Top 50 HighlightsIndian Pharma Market Top 50 Highlights
Indian Pharma Market Top 50 Highlights
Anup Soans
 
Pharma industry an overview
Pharma industry an overviewPharma industry an overview
Pharma industry an overview
Shyamsunder Panchavati
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
Amit Roy
 
Demonetization - Impact on Indian Pharma
Demonetization - Impact on Indian PharmaDemonetization - Impact on Indian Pharma
Demonetization - Impact on Indian Pharma
Anup Soans
 
Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015
Anup Soans
 
Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?
Anup Soans
 
Marketing Plan of Esomeprazole
Marketing Plan of EsomeprazoleMarketing Plan of Esomeprazole
Marketing Plan of Esomeprazole
Animesh Gupta
 
How Many Pharma Companies in India?
How Many Pharma Companies in India?How Many Pharma Companies in India?
How Many Pharma Companies in India?
Anup Soans
 
Pharmaceutical Sectore Report - January 2017
Pharmaceutical Sectore Report - January 2017Pharmaceutical Sectore Report - January 2017
Pharmaceutical Sectore Report - January 2017
India Brand Equity Foundation
 

Viewers also liked (20)

India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015India Pharmaceutical Market Reflection Report Mar 2015
India Pharmaceutical Market Reflection Report Mar 2015
 
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACSIndian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
Indian Pharma Market - April 2015 Sales Overview by AIOCD AWACS
 
Indian Pharma Market 2015
Indian Pharma Market 2015 Indian Pharma Market 2015
Indian Pharma Market 2015
 
Indian Pharma Market - IPM Overview June 2015
Indian Pharma Market - IPM Overview June 2015Indian Pharma Market - IPM Overview June 2015
Indian Pharma Market - IPM Overview June 2015
 
indian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overviewindian Pharmaceutical industry export import overview
indian Pharmaceutical industry export import overview
 
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
Indian Pharmaceutical Export Market - Top Export Destinations for Indian Phar...
 
Indian Pharma Top 50 Companies - May 2014
Indian Pharma Top 50 Companies - May 2014Indian Pharma Top 50 Companies - May 2014
Indian Pharma Top 50 Companies - May 2014
 
Indian Pharma Industry
Indian Pharma IndustryIndian Pharma Industry
Indian Pharma Industry
 
Pharmaceutical industry India
Pharmaceutical industry IndiaPharmaceutical industry India
Pharmaceutical industry India
 
Indian Pharmaceutical Industry
Indian Pharmaceutical IndustryIndian Pharmaceutical Industry
Indian Pharmaceutical Industry
 
India Market Reflection Report Feb 2015
India Market Reflection Report Feb 2015India Market Reflection Report Feb 2015
India Market Reflection Report Feb 2015
 
Indian Pharma Market Top 50 Highlights
Indian Pharma Market Top 50 HighlightsIndian Pharma Market Top 50 Highlights
Indian Pharma Market Top 50 Highlights
 
Pharma industry an overview
Pharma industry an overviewPharma industry an overview
Pharma industry an overview
 
Pharmaceutical Industry
Pharmaceutical IndustryPharmaceutical Industry
Pharmaceutical Industry
 
Demonetization - Impact on Indian Pharma
Demonetization - Impact on Indian PharmaDemonetization - Impact on Indian Pharma
Demonetization - Impact on Indian Pharma
 
Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015Indian Pharma Market - Sales Highlights of May 2015
Indian Pharma Market - Sales Highlights of May 2015
 
Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?Why are there only 15% to 20% Women in Indian Pharma?
Why are there only 15% to 20% Women in Indian Pharma?
 
Marketing Plan of Esomeprazole
Marketing Plan of EsomeprazoleMarketing Plan of Esomeprazole
Marketing Plan of Esomeprazole
 
How Many Pharma Companies in India?
How Many Pharma Companies in India?How Many Pharma Companies in India?
How Many Pharma Companies in India?
 
Pharmaceutical Sectore Report - January 2017
Pharmaceutical Sectore Report - January 2017Pharmaceutical Sectore Report - January 2017
Pharmaceutical Sectore Report - January 2017
 

More from Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
Anup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
Anup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
Anup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
Anup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
Anup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
Anup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
Anup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
Anup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
Anup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
Anup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Anup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
Anup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
Anup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
Anup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
Anup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
Anup Soans
 

More from Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma Market Top 50 Ranking - June 2014 by AIOCD Pharmasofttech AWACS

  • 1. Val in Crs MAT MTH Val (Cr) MS% GR% Val (Cr) MS% GR% COMPANY MAT MTH 77529 100 6.7 6636 100 10.4 IPM 1 1 4218 5.44 15.8 349 5.26 16.1 Sun Pharma 1 1 2 2 3838 4.95 6.2 315 4.74 11.7 Cipla 2 2 3 3 3082 3.97 5.7 258 3.89 7.2 Zydus Cadila 4 3 4 5 3060 3.95 2.1 242 3.65 4.1 Ranbaxy 3 4 5 4 2759 3.56 5.7 246 3.71 14.8 Mankind 8 8 6 8 2697 3.48 -1.1 220 3.31 -1.1 Abbott HC 6 7 7 7 2694 3.47 -15.5 226 3.41 -7.0 Glaxo 5 6 8 6 2621 3.38 12.7 231 3.49 20.6 Lupin 7 5 9 9 2403 3.10 9.1 207 3.13 8.0 Alkem 9 9 10 11 2244 2.89 3.2 185 2.79 4.8 Pfizer 10 12 11 10 2102 2.71 13.3 200 3.01 29.5 Macleods 11 10 12 12 1975 2.55 14.1 185 2.79 26.6 Intas 12 11 13 13 1942 2.51 0.6 172 2.59 7.7 Sanofi-India 13 13 14 14 1902 2.45 14.7 170 2.56 17.1 Aristo 15 15 15 15 1724 2.22 2.7 156 2.34 12.0 Torrent 14 14 16 18 1688 2.18 16.7 136 2.05 16.9 Glenmark 16 17 17 16 1658 2.14 7.2 147 2.22 17.4 Dr. Reddys 17 16 18 17 1560 2.01 10.6 137 2.07 15.6 Micro Lab 19 19 19 19 1528 1.97 8.4 132 1.99 13.5 Abbott 18 18 20 22 1410 1.82 8.5 115 1.74 3.6 USV 20 22 21 20 1400 1.81 21.5 123 1.86 28.6 Ipca 21 20 22 21 1345 1.73 22.0 118 1.78 23.8 Emcure 22 21 23 23 1230 1.59 4.7 98 1.48 8.7 Wockhardt 23 23 24 24 1131 1.46 -1.5 93 1.40 -2.6 Novartis 24 24 25 25 1064 1.37 10.2 85 1.28 9.1 Alembic 25 25 26 27 831 1.07 3.9 66 0.99 -9.8 Zuventus 27 28 27 26 821 1.06 3.6 71 1.07 15.1 FDC 26 26 28 28 799 1.03 8.9 64 0.97 9.4 Unichem 28 27 29 29 686 0.89 14.7 61 0.93 7.3 Novo Nordisk 29 29 30 30 613 0.79 10.0 54 0.81 3.5 Cadila 30 30 31 32 599 0.77 7.1 51 0.76 12.8 Indoco Remedies 32 33 32 31 575 0.74 12.3 52 0.78 17.4 Franco 33 31 33 33 570 0.74 22.5 50 0.75 8.9 Eris 31 32 34 36 500 0.64 15.8 41 0.61 8.6 MSD 34 35 35 34 477 0.62 5.4 43 0.64 19.4 Himalaya 35 34 36 35 470 0.61 10.4 41 0.62 12.2 Merck 36 36 37 39 428 0.55 2.5 35 0.53 14.9 Blue Cross 38 41 38 37 412 0.53 11.4 39 0.58 19.5 JB Chemicals 37 37 39 45 392 0.51 13.6 29 0.43 -7.6 Astrazeneca 39 46 40 38 378 0.49 -0.2 37 0.55 7.9 Raptakos, Brett 40 38 41 41 378 0.49 -12.7 34 0.51 -13.2 Bharat Serums 41 40 42 40 378 0.49 23.7 34 0.52 21.5 Meyer Organics 42 39 43 51 349 0.45 11.6 27 0.40 10.3 Hetero 47 55 44 43 342 0.44 14.4 33 0.49 16.9 Medley 45 43 45 47 332 0.43 9.4 29 0.43 12.3 Janssen 43 45 46 44 331 0.43 9.8 31 0.47 14.7 Wallace 49 44 With Bonus Units at Full Value Witho Rank MAT June-14 Jun-14 Rank
  • 2. 47 49 331 0.43 1.1 28 0.42 5.2 Win-Medicare 44 49 48 42 330 0.43 36.8 33 0.49 52.6 Akumentis 46 42 49 58 321 0.41 8.9 23 0.34 8.9 Fourrts 50 58 50 46 311 0.40 2.6 29 0.43 0.1 Albert David 48 48
  • 3. Val (Cr) MS% GR% Val (Cr) MS% GR% 74585 100 6.8 6395 100 10.9 4123 5.53 14.9 343 5.36 16.4 3605 4.83 9.1 296 4.63 13.9 2893 3.88 5.6 242 3.79 6.5 2960 3.97 2.1 234 3.67 4.2 2339 3.14 7.4 212 3.31 18.5 2612 3.50 -1.5 213 3.34 -0.5 2663 3.57 -14.7 224 3.51 -5.6 2564 3.44 12.6 227 3.55 21.2 2237 3.00 9.3 194 3.04 9.8 2193 2.94 3.5 182 2.84 5.3 1970 2.64 13.0 187 2.93 29.5 1951 2.62 13.6 183 2.86 26.8 1907 2.56 0.4 168 2.63 8.1 1674 2.24 12.0 148 2.32 15.3 1689 2.26 3.0 152 2.38 12.1 1639 2.20 16.3 132 2.06 16.3 1624 2.18 6.3 144 2.26 17.1 1490 2.00 11.2 131 2.05 15.8 1517 2.03 8.0 131 2.05 13.6 1404 1.88 8.4 115 1.80 3.7 1332 1.79 21.4 118 1.85 30.2 1318 1.77 22.2 116 1.81 23.9 1206 1.62 4.5 97 1.51 9.3 1092 1.46 -0.8 90 1.41 -1.3 1032 1.38 10.8 83 1.30 10.3 793 1.06 4.2 63 0.98 -9.7 798 1.07 3.4 69 1.08 14.2 782 1.05 8.2 63 0.99 9.3 685 0.92 14.6 61 0.96 7.1 591 0.79 9.9 52 0.81 3.5 561 0.75 7.3 47 0.74 12.7 554 0.74 11.7 50 0.78 17.2 567 0.76 22.3 49 0.77 8.9 498 0.67 15.4 40 0.63 7.7 475 0.64 5.0 43 0.67 19.8 458 0.61 9.0 40 0.63 11.1 393 0.53 4.2 33 0.51 14.7 396 0.53 11.3 37 0.58 19.7 387 0.52 12.8 28 0.44 -7.5 373 0.50 -0.4 36 0.57 8.0 371 0.50 -13.1 33 0.52 -12.8 366 0.49 23.6 33 0.52 21.9 318 0.43 12.0 24 0.38 10.7 325 0.44 15.1 31 0.49 16.9 332 0.44 9.4 28 0.45 12.3 305 0.41 15.5 30 0.48 27.6 Without Bonus Units MAT June-14 Jun-14
  • 4. 326 0.44 -0.3 27 0.43 3.4 324 0.43 38.6 32 0.50 53.0 304 0.41 7.9 22 0.34 8.4 305 0.41 2.6 28 0.44 -0.1